Healthcare Customers Challenged, BNPL Brings Flexibility, Allbirds’ Path to Profitability

By  |  November 4, 2021
 | 
Pharmacy

The Affirm president sees BNPL offerings as a way to increase flexibility and transparency for consumers and merchants. Plus, Allbirds goes public and expects to turn a profit quickly, and CVS says healthcare customers are “incredibly challenged” by the muddled landscape.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    Data:

    $2.16B: Value of sustainable shoemaker Allbirds.

    77%: Share of consumers who say brands’ sustainability and environmental responsibility is at least moderately important.

    56%: Portion of consumers who made telemedicine appointments in the past 12 months.

    11M: Number of COVID-19 vaccines given at CVS in 2021 Q3, down from 17 million in Q2.

    Advertisement: Scroll to Continue

    29M: Number of consumers who have used a buy now, pay later (BNPL) solution.


    Recommended

    telecom AI

    More Than Half of Telecoms Run AI Agents in Production, Google Cloud Finds

    Tech-Focused Erebor Bank Gains FDIC Approval for Deposit Insurance

    OpenAI Hires Former UK Treasury Chief to Lead ‘OpenAI for Countries’ Initiative

    US Considers Fining EU Companies in Response to Bloc's Regulatory Actions

    See More In: , , , , , , ,